CKSW (MM)

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G/A

 

(Rule 13d-102)

 

Under the Securities Exchange Act of 1934
(Amendment No. 11)*

 

ClickSoftware Technologies Ltd.

(Name of Issuer)

 

Ordinary Shares

(Title of Class of Securities)

 

M25082104

(CUSIP Number)

 

December 31, 2011

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

	£	Rule 13d-1(b)
	£	Rule 13d-1(c)
	S	Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

CUSIP No. M25082104

13G/A

Page 2 of 6 Pages

 

1.	Names of Reporting Persons   Dr. Moshe BenBassat
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* ( See Instructions) (a) £ (b) £
3.	SEC Use Only
4.	Citizenship or Place of Organization     Israel
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5.	Sole Voting Power   934,125
		6.	Shared Voting Power   1,382,162
		7.	Sole Dispositive Power   934,125
		8.	Shared Dispositive Power   1,382,162
9.	Aggregate Amount Beneficially Owned by Each Reporting Person   2,316,287 *
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares                                                          £ ( See Instructions)
11.	Percent of Class Represented by Amount in Row (9)   7.4 %
12.	Type of Reporting Person ( See Instructions)   IN

 * Consists of 934,125 options to purchase the Company's ordinary shares exercisable by February 29, 2012 held by Dr. BenBassat, 1,342,579 shares held by Singuno Pte. Ltd., a Singapore company controlled by Dr. BenBassat, and 39,583 options to purchase the Company's ordinary shares exercisable by February 29, 2012 held by Plataine Technologies Ltd., an Israeli corporation controlled by Idit Ben Bassat and Dr. BenBassat (the “Plataine Options”). The Plataine Options were granted by the Company in connection with services provided through Plataine by Dr. BenBassat to the Company.  The Plataine options are reported as  beneficially owned in their entirety by both Idit BenBassat on the Schedule 13G she has filed and by Dr. BenBassat herein because of their shared control of Plataine, but constitute only a single set of options held by Plataine. Does not include 1,581,944 shares beneficially owned by Dr. BenBassat's spouse, Idit BenBassat, as to which Dr. BenBassat disclaims beneficial ownership.

 

 

CUSIP No. M25082104

13G/A

Page 3 of 6 Pages

 

Item 1(a).

Name of Issuer:

 

ClickSoftware Technologies Ltd.

 

Item 1(b).

Address of Issuer's Principal Executive Offices:

 

94 Em Hamoshavot Road

Petach Tikva 49527, Israel

 

Item 2(a).

Name of Person Filing:

 

This Statement is filed on behalf of each of the following persons (collectively, the "Reporting Persons"):

 

Dr. Moshe BenBassat.

 

Item 2(b).

Address of Principal Offices or, if None, Residence:

 

The addresses of the Reporting Persons are:

 

Dr. Moshe BenBassat - 411 Waverly Oak Road, # 331, Waltham, MA 02452 USA

 

Item 2(c).

Citizenship:

 

Dr. Moshe BenBassat is an Israeli citizen.

 

Item 2(d).

Title of Class of Securities:

 

Ordinary Shares.

 

Item 2(e).

CUSIP Number:

 

M25082104.

 

Item 3.

If the Statement is being filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the filing person is a:

 

Not applicable.

 

(a)	£		Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	£		Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	£		Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	£		Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	£		An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
(f)	£		An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
(g)	£		A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

 

 

CUSIP No. M25082104

13G/A

Page 4 of 6 Pages

 

(h)	£		A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	£		A church plan that is excluded from the definition of an investment company under Section
			3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
(j)	£		A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
(k)	£		Group, in accordance with §240.13d-1(b)(1)(ii)(K).

 

If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:__________________________________________________________________________

 

Item 4.

Ownership.

 

(a)

Amount beneficially owned:

 

1. Dr. Moshe BenBassat:             2,316,287 *

 

(b)

Percent of class:

 

1. Dr. Moshe BenBassat:             7.4%

 

(c)

Number of shares as to which such person has:

 

(i)

Sole power to vote or direct the vote:

 

1. Dr. Moshe BenBassat:            934,125

 

(ii)

Shared power to vote or direct the vote:

 

1. Dr. Moshe BenBassat:           1,382,162

 

(iii)

Sole power to dispose or to direct the disposition of:

 

1. Dr. Moshe BenBassat:           934,125

 

(iv)

Shared power to dispose or to direct the disposition of:

 

1. Dr. Moshe BenBassat:          1,382,162

 

* Consists of 934,125 options to purchase the Company's ordinary shares exercisable by February 29, 2012 held by Dr. BenBassat, 1,342,579 shares held by Singuno Pte. Ltd., a Singapore company controlled by Dr. BenBassat, and 39,583 options to purchase the Company's ordinary shares exercisable by February 29, 2012 held by Plataine Technologies Ltd., an Israeli corporation controlled by Idit Ben Bassat and Dr. BenBassat (the “Plataine Options”). The Plataine Options were granted by the Company in connection with services provided through Plataine by Dr. BenBassat to the Company.  The Plataine options are reported as  beneficially owned in their entirety by both Idit BenBassat on the Schedule 13G she has filed and by Dr. BenBassat herein because of their shared control of Plataine, but constitute only a single set of options held by Plataine. Does not include 1,581,944 shares beneficially owned by Dr. BenBassat's spouse, Idit BenBassat, as to which Dr. BenBassat disclaims beneficial ownership.

 

CUSIP No. M25082104

13G/A

Page 5 of 6 Pages

 

Item 5.

Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person had ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following £ .

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

 

Not applicable.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

 

Not applicable.

 

Item 8.

Identification and Classification of Members of the Group.

 

Not applicable.

 

Item 9.

Notice of Dissolution of Group.

 

Not applicable.

 

Item 10.

Certification.

 

(a) Not applicable.

 

(b) Not applicable.

 

(c) Not applicable.

 

 

CUSIP No. M25082104

13G/A

Page 6 of 6 Pages

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

	February 14, 2012
	(Date)
	DR. MOSHE BENBASSAT
	/s/ Moshe BenBassat
	(Signature)

 

Attention. Intentional misstatements or omissions of fact constitute Federal criminal violations (s ee 18 U.S.C. 1001).